Event Details

Dr. Matthew During, Founder, President and Chief Scientific Officer to present at the Antiepileptic Drug and Device Trials XIV Conference

Friday, May 19, 2017  

Webcast Presentation

Title
Dr. Matthew During, Founder, President and Chief Scientific Officer to present at the Antiepileptic Drug and Device Trials XIV Conference
Date / Time
May 19, 2017
Location
Turnberry Isle Miami Hotel
1999 W Country Club Drive
Aventura FL 
Description
OV935/TAK935, a novel NMDA modulator under development for epileptic encephalopathies